Bertil Olsson
1 – 10 of 161
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2018
-
Mark
Bastubad kan vara bra vid ett antal sjukdomar – men fler studier krävs - Det vetenskapliga underlaget ännu inte tillräckligt för allmänna rekommendationer
(
- Contribution to journal › Article
- 2017
-
Mark
Atrial time and voltage dispersion are both needed to predict new-onset atrial fibrillation in ischemic stroke patients
(
- Contribution to journal › Article
- 2015
-
Mark
Predictors of new onset atrial fibrillation during 10-year follow-up after first-ever ischemic stroke.
(
- Contribution to journal › Article
-
Mark
Exposure- response for biomarkers of anticoagulant effects by the oral direct thrombin inhibitor AZD0837 in patients with atrial fibrillation.
(
- Contribution to journal › Article
- 2014
-
Mark
Documentation of atrial fibrillation prior to first-ever ischemic stroke.
(
- Contribution to journal › Article
-
Mark
Atrial fibrillation in patients with ischaemic stroke in the Swedish national patient registers: how much do we miss?
(
- Contribution to journal › Article
- 2012
-
Mark
Ventricular repolarization sequences on the epicardium and endocardium. Monophasic action potential mapping in healthy pigs
(
- Contribution to journal › Article
- 2011
-
Mark
Oral direct thrombin inhibitor AZD0837 for the prevention of stroke and systemic embolism in patients with non-valvular atrial fibrillation: A Phase II study of AZD0837 in patients who are appropriate for but unable or unwilling to take vitamin K antagonist therapy
(
- Contribution to journal › Article
- 2010
-
Mark
Increased Global Dispersion of Ventricular Repolarization during Left Ventricular Epicardial Pacing: In Vivo Evaluation by Monophasic Action Potential Mapping in Swine
(
- Contribution to journal › Published meeting abstract
-
Mark
Safety and tolerability of an immediate-release formulation of theoral direct thrombin inhibitor AZD0837 in the prevention of stroke and systemic embolism in patients with atrial fibrillation.
(
- Contribution to journal › Article